Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Which is more tax-efficient for retirement: ETF or mutual fund? A clear comparison of tax features and practical implications.
28,114 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
A prominent smart-money investor boosted bets on Intel as the AI-driven semiconductor rally intensifies. The rest of ...
As micron's earnings report almost arrives, investors weigh whether the AI memory boom can sustain MU's meteoric run....
A surprising all-stock deal sent ON Semiconductor lower, wiping out gains from a strong AI data center narrative. Her...
Lumentum’s fiery stock rally this year has propelled the optics company into the top tier of the market, signaling a ...
XRP is testing a breakout near $1.50 as institutional inflows and rising derivatives support a bullish setup. But a m...
When authorities in Italy halted two high-profile concerts, fans and promoters faced more than disappointment. This g...
The Pennsylvania House approved HB 2186, a by-right ADU reform, in a bipartisan vote and sent the bill to the Senate....
When a legendary investor hands the reins, the next era often comes with bolder bets. This article examines berkshire...
A JPMorgan-led projection suggests about $165 billion in stock sales could hit markets as major funds rebalance portf...
Bitcoin weakness pushes STRC to new lows as strategy's Saylor acknowledges 'volatility' as a real market test. This g...
A moment of misread cues, a tense room, and suddenly a career trajectory could pivot from spotlight to setback. This ...